STM publisher Elsevier, Netherlands, is marking the 10th anniversary of publication of its journal International Immunopharmacology by organising an International Immunopharmacology Conference on Regulatory Myeloid Cells. The conference is scheduled for October 21-24, 2010 in Arlington, near Washington DC.
Since its inception in 2001 International Immunopharmacology has been a primary vehicle for the publication of peer-reviewed original research papers and review articles pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Under the guidance of the Editor in Chief, James Talmadge of the University of Nebraska Medical Center in Omaha, the journal has developed into an internationally respected, high quality platform for researchers and clinicians interested in examining how the immune system interacts with pharmacologically active agents.
The conference is expected to bring together scientists and clinicians from the diverse fields in which myeloid cells have a critical role, to engender productive discussions, novel hypotheses and foster new collaborations, all of which are critical to the development of this exciting new field. The Organizing Committee has reportedly developed a strong programme with speakers covering many of the more exciting research areas developing in this important field. The programme of the conference is now available online at www.immunopharmacology.elsevier.com.
Search for more conferences
